Skip to content
HeyJared

Tom Chivers

Reporter

Indexed articles, last 90 days
4
Latest publication
Aug 3, 2026
Outlet visibility, for yahoo.com
Top 1K sites
Earliest in this view
Jul 14, 2026
The latest indexed work is over 30 days old. There may be a gap in what we hold.

Latest articles

  1. Article · Aug 3, 2026 · Tom Chivers

    DeepSeek releases cheaper new AI model as China's price war intensifies (opens the original)

    Excerpt · English

    Read excerpt

    Chinese AI giant DeepSeek released its latest model at a steep discount, as the country's tech price war grows fiercer. The open-weight V4-Flash has enhanced agent capabilities — although it still trails the leading Chinese model, Moonshot's Kimi K3. A 50% cut in token costs, and a pause on bringing in a previously announced dynamic-pricing mechanism that would have doubled costs during peak hours, suggests DeepSeek is competing for market share. Beijing, a significant investor in the company, h

  2. Article · Jul 30, 2026 · Tom Chivers

    Tech giants see diverging results from the AI buildout (opens the original)

    Excerpt · Critical tone · English

    Read excerpt

    Samsung and Meta's contrasting results highlighted the diverging fortunes of the companies supplying — and paying for — the AI buildout. The South Korean giant's chipmaking division posted a 250-fold increase in quarterly operating profit as demand for semiconductors soared. Meta, however, announced lower-than-anticipated revenue forecasts and an $8 billion hit to free cash flow as it predicted over $130 billion in capital expenditure this year, sending shares tumbling 11%. Rival Alphabet also r

  3. Article · Jul 21, 2026 · Tom Chivers

    Fervor over top-selling drugs fuels biotech dealmaking (opens the original)

    Excerpt · English

    Read excerpt

    Biotech is commanding attention from dealmakers and investors. Pharma companies have acquired 37 biotech firms worth at least $1 billion this year, more than all of 2025, as they race to bolster pipelines before several blockbuster drugs lose their patent protections in the coming years. The Trump administration's light-touch regulatory approach and windfalls from top-selling drugs are also driving M&A, the Financial Times noted. Against this backdrop, biotech and pharma firms' IPOs are producin

  4. Article · Jul 14, 2026 · Tom Chivers

    Oil prices surge 10% as US-Iran conflict reignites (opens the original)

    Excerpt · English

    Read excerpt

    Oil prices jumped 10% Monday, the biggest single-day rise since 2020, signaling that markets do not expect a return to pre-war norms as conflict between the US and Iran reignited. US President Donald Trump said he would re-impose a blockade and start charging tolls on the Strait of Hormuz, effectively ending a month-long ceasefire. Trump has few good options, The New York Times reported: Neither warfare nor diplomacy has achieved his goals, and he is under political pressure to focus on domestic

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

Top 1K sites

For yahoo.com, the outlet · Measured Aug 1, 2026

Website popularity band, not a count of readers or article views.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Tom Chivers